Overview

This trial is active, not recruiting.

Condition eye disease
Sponsor Association for Innovation and Biomedical Research on Light and Image
Start date September 2015
End date December 2016
Trial size 100 participants
Trial identifier NCT02500862, 4C-2015-08

Summary

Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI

United States No locations recruiting
Other Countries No locations recruiting

Primary Outcomes

Measure
Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI.
time frame: 10 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre, and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2 "Consentimento Informado para tratamento de dados". Exclusion criteria:

Additional Information

Official title Characterization of Potential Biomarkers of Eye Disease and Vision Loss.
Principal investigator Maria L Ribeiro, MsC
Description This is a registry study. Only patients followed under the clinical practice at AIBILI Clinical Trial Centre, and with a signed informed consent form will be included. Based on the clinical information collected under the clinical practice, and based on patients' characteristics, scientific questions will be raised and data will be collected and analysed accordingly. Any procedure performed under clinical practice that may allow for the characterization of the disease and/or for the identification of potential biomarkers will be collected and analysed.
Trial information was received from ClinicalTrials.gov and was last updated in April 2016.
Information provided to ClinicalTrials.gov by Association for Innovation and Biomedical Research on Light and Image.